nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—CYP3A4—Topotecan—lung cancer	0.0533	0.142	CbGbCtD
Sibutramine—CYP3A4—Gefitinib—lung cancer	0.0487	0.13	CbGbCtD
Sibutramine—CYP3A4—Teniposide—lung cancer	0.0473	0.126	CbGbCtD
Sibutramine—CYP3A4—Vinorelbine—lung cancer	0.0375	0.1	CbGbCtD
Sibutramine—CYP3A4—Crizotinib—lung cancer	0.0299	0.0796	CbGbCtD
Sibutramine—CYP3A4—Erlotinib—lung cancer	0.0288	0.0768	CbGbCtD
Sibutramine—CYP3A4—Paclitaxel—lung cancer	0.0264	0.0703	CbGbCtD
Sibutramine—CYP3A4—Irinotecan—lung cancer	0.026	0.0694	CbGbCtD
Sibutramine—CYP3A4—Vinblastine—lung cancer	0.0231	0.0617	CbGbCtD
Sibutramine—CYP3A4—Etoposide—lung cancer	0.0208	0.0556	CbGbCtD
Sibutramine—CYP3A4—Docetaxel—lung cancer	0.0191	0.0508	CbGbCtD
Sibutramine—CYP3A4—Doxorubicin—lung cancer	0.0142	0.0379	CbGbCtD
Sibutramine—SLC6A3—NRF2 pathway—GSTM2—lung cancer	0.000634	0.00756	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—KEAP1—lung cancer	0.00063	0.00752	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—TOP1—lung cancer	0.000627	0.00747	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—GSTA4—lung cancer	0.000613	0.00731	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—NKX2-1—lung cancer	0.000611	0.00728	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.000603	0.00719	CbGpPWpGaD
Sibutramine—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—lung cancer	0.000598	0.00713	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—GSTA2—lung cancer	0.000598	0.00713	CbGpPWpGaD
Sibutramine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—lung cancer	0.000579	0.0069	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—GSTA1—lung cancer	0.000577	0.00687	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—GSTA3—lung cancer	0.000577	0.00687	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—ABCC3—lung cancer	0.00057	0.0068	CbGpPWpGaD
Sibutramine—CYP3A4—Tryptophan metabolism—HSD17B10—lung cancer	0.000559	0.00667	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—KEAP1—lung cancer	0.000542	0.00646	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—UGT1A1—lung cancer	0.000536	0.00639	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—GSTA4—lung cancer	0.000527	0.00629	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—GRIK3—lung cancer	0.000524	0.00625	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—FOXM1—lung cancer	0.000518	0.00618	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.000516	0.00615	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—GSTA2—lung cancer	0.000514	0.00613	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—GSTA3—lung cancer	0.000511	0.00609	CbGpPWpGaD
Sibutramine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—lung cancer	0.000508	0.00606	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—NFE2L2—lung cancer	0.000508	0.00606	CbGpPWpGaD
Sibutramine—CYP3A4—Xenobiotics—CYP2A6—lung cancer	0.0005	0.00596	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—GSTA1—lung cancer	0.000496	0.00591	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—ABCC3—lung cancer	0.00049	0.00585	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—TGFA—lung cancer	0.000485	0.00578	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—SOX2—lung cancer	0.000482	0.00575	CbGpPWpGaD
Sibutramine—CYP3A4—Tamoxifen metabolism—CYP2A6—lung cancer	0.000481	0.00573	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—KEAP1—lung cancer	0.00048	0.00573	CbGpPWpGaD
Sibutramine—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—lung cancer	0.00047	0.0056	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—GSTA4—lung cancer	0.000467	0.00557	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—ALDOA—lung cancer	0.000467	0.00557	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—UGT1A1—lung cancer	0.000461	0.0055	CbGpPWpGaD
Sibutramine—CYP3A4—Estrogen metabolism—NQO1—lung cancer	0.000457	0.00545	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.000457	0.00545	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—GSTA2—lung cancer	0.000455	0.00543	CbGpPWpGaD
Sibutramine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—lung cancer	0.000448	0.00534	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—GSTA1—lung cancer	0.000439	0.00524	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—NFE2L2—lung cancer	0.000437	0.00521	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—GCLC—lung cancer	0.000437	0.00521	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—CYP2A6—lung cancer	0.000437	0.00521	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—ABCC3—lung cancer	0.000434	0.00518	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—CHRNB4—lung cancer	0.000427	0.00509	CbGpPWpGaD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—lung cancer	0.000427	0.00509	CbGpPWpGaD
Sibutramine—CYP3A4—Xenobiotics—CYP2E1—lung cancer	0.000425	0.00507	CbGpPWpGaD
Sibutramine—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—lung cancer	0.000421	0.00502	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—TGFA—lung cancer	0.000417	0.00497	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—TF—lung cancer	0.00041	0.00489	CbGpPWpGaD
Sibutramine—CYP3A4—Tamoxifen metabolism—CYP2E1—lung cancer	0.000409	0.00488	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—UGT1A1—lung cancer	0.000408	0.00487	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—AHR—lung cancer	0.000404	0.00481	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—GRIK3—lung cancer	0.000402	0.00479	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—CHRNA5—lung cancer	0.000397	0.00473	CbGpPWpGaD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—lung cancer	0.00039	0.00465	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—NFE2L2—lung cancer	0.000387	0.00462	CbGpPWpGaD
Sibutramine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—lung cancer	0.000378	0.00451	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—GCLC—lung cancer	0.000376	0.00448	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—CYP2A6—lung cancer	0.000376	0.00448	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—TGFA—lung cancer	0.000369	0.0044	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—NQO1—lung cancer	0.000367	0.00438	CbGpPWpGaD
Sibutramine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—lung cancer	0.000365	0.00435	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—ADCY1—lung cancer	0.00036	0.00429	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	0.000358	0.00426	CbGpPWpGaD
Sibutramine—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.000353	0.00421	CbGpPWpGaD
Sibutramine—CYP3A4—Estrogen metabolism—GSTM1—lung cancer	0.000351	0.00418	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000346	0.00412	CbGpPWpGaD
Sibutramine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	0.000343	0.00409	CbGpPWpGaD
Sibutramine—SLC6A3—Alpha-synuclein signaling—SRC—lung cancer	0.000338	0.00403	CbGpPWpGaD
Sibutramine—SLC6A3—Dopaminergic Neurogenesis—STAT3—lung cancer	0.000335	0.00399	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—GCLC—lung cancer	0.000333	0.00397	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—CYP2A6—lung cancer	0.000333	0.00397	CbGpPWpGaD
Sibutramine—CYP3A4—Estrogen metabolism—CYP1A1—lung cancer	0.000332	0.00396	CbGpPWpGaD
Sibutramine—SLC6A3—Parkinsons Disease Pathway—CASP3—lung cancer	0.00033	0.00393	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—CHRNB4—lung cancer	0.000327	0.0039	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—CHRNA3—lung cancer	0.000324	0.00386	CbGpPWpGaD
Sibutramine—CYP3A4—Irinotecan Pathway—APC—lung cancer	0.000318	0.0038	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—NQO1—lung cancer	0.000316	0.00377	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—GSTP1—lung cancer	0.000306	0.00365	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000306	0.00365	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—GNG11—lung cancer	0.000306	0.00365	CbGpPWpGaD
Sibutramine—CYP3A4—Xenobiotics—CYP1A1—lung cancer	0.000306	0.00364	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—CHRNA5—lung cancer	0.000304	0.00363	CbGpPWpGaD
Sibutramine—CYP3A4—Tamoxifen metabolism—CYP1A1—lung cancer	0.000294	0.0035	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.00029	0.00346	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—AVP—lung cancer	0.000284	0.00339	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—GSTM1—lung cancer	0.000282	0.00336	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—NQO1—lung cancer	0.00028	0.00334	CbGpPWpGaD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	0.000278	0.00332	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—ADCY1—lung cancer	0.000275	0.00328	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—HES1—lung cancer	0.000269	0.0032	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL10—lung cancer	0.000267	0.00318	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—GSTP1—lung cancer	0.000264	0.00314	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000262	0.00313	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—CHRNA3—lung cancer	0.000248	0.00296	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—GSTM1—lung cancer	0.000242	0.00289	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—GNG11—lung cancer	0.000235	0.0028	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—GSTP1—lung cancer	0.000233	0.00278	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000232	0.00277	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—AVP—lung cancer	0.000232	0.00277	CbGpPWpGaD
Sibutramine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	0.000228	0.00272	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.000225	0.00268	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—TYMS—lung cancer	0.000221	0.00263	CbGpPWpGaD
Sibutramine—CYP3A4—Tryptophan metabolism—CYP2E1—lung cancer	0.000218	0.0026	CbGpPWpGaD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	0.000217	0.00259	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—GSTM1—lung cancer	0.000215	0.00256	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—ADCY1—lung cancer	0.000211	0.00251	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.000208	0.00248	CbGpPWpGaD
Sibutramine—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000205	0.00244	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL6R—lung cancer	0.000184	0.0022	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000184	0.00219	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.000177	0.00211	CbGpPWpGaD
Sibutramine—CYP3A4—Tryptophan metabolism—CAT—lung cancer	0.000175	0.00209	CbGpPWpGaD
Sibutramine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000174	0.00208	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTM2—lung cancer	0.00017	0.00203	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—CNDP2—lung cancer	0.00017	0.00203	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000168	0.00201	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	0.000168	0.002	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—AVP—lung cancer	0.000162	0.00194	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000157	0.00187	CbGpPWpGaD
Sibutramine—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	0.000157	0.00187	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—CYP2A7—lung cancer	0.000154	0.00184	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	0.000152	0.00181	CbGpPWpGaD
Sibutramine—Arthralgia—Docetaxel—lung cancer	0.000151	0.000279	CcSEcCtD
Sibutramine—Chest pain—Docetaxel—lung cancer	0.000151	0.000279	CcSEcCtD
Sibutramine—Myalgia—Docetaxel—lung cancer	0.000151	0.000279	CcSEcCtD
Sibutramine—Nausea—Vinorelbine—lung cancer	0.00015	0.000278	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Etoposide—lung cancer	0.00015	0.000277	CcSEcCtD
Sibutramine—Dyspepsia—Paclitaxel—lung cancer	0.00015	0.000277	CcSEcCtD
Sibutramine—Body temperature increased—Cisplatin—lung cancer	0.00015	0.000277	CcSEcCtD
Sibutramine—Asthenia—Irinotecan—lung cancer	0.00015	0.000277	CcSEcCtD
Sibutramine—Pain—Etoposide—lung cancer	0.000149	0.000275	CcSEcCtD
Sibutramine—Constipation—Etoposide—lung cancer	0.000149	0.000275	CcSEcCtD
Sibutramine—Dysuria—Doxorubicin—lung cancer	0.000148	0.000274	CcSEcCtD
Sibutramine—Decreased appetite—Paclitaxel—lung cancer	0.000148	0.000274	CcSEcCtD
Sibutramine—Dry mouth—Docetaxel—lung cancer	0.000147	0.000272	CcSEcCtD
Sibutramine—Haemoglobin—Methotrexate—lung cancer	0.000147	0.000272	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000147	0.000272	CcSEcCtD
Sibutramine—Haemorrhage—Methotrexate—lung cancer	0.000147	0.000271	CcSEcCtD
Sibutramine—Pollakiuria—Doxorubicin—lung cancer	0.000146	0.000271	CcSEcCtD
Sibutramine—Asthenia—Gemcitabine—lung cancer	0.000146	0.00027	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000146	0.00174	CbGpPWpGaD
Sibutramine—Pain—Paclitaxel—lung cancer	0.000146	0.000269	CcSEcCtD
Sibutramine—Constipation—Paclitaxel—lung cancer	0.000146	0.000269	CcSEcCtD
Sibutramine—Confusional state—Docetaxel—lung cancer	0.000146	0.000269	CcSEcCtD
Sibutramine—Pharyngitis—Methotrexate—lung cancer	0.000145	0.000269	CcSEcCtD
Sibutramine—Photosensitivity reaction—Doxorubicin—lung cancer	0.000145	0.000267	CcSEcCtD
Sibutramine—Anaphylactic shock—Docetaxel—lung cancer	0.000144	0.000267	CcSEcCtD
Sibutramine—Oedema—Docetaxel—lung cancer	0.000144	0.000267	CcSEcCtD
Sibutramine—Weight increased—Doxorubicin—lung cancer	0.000144	0.000267	CcSEcCtD
Sibutramine—Pruritus—Gemcitabine—lung cancer	0.000144	0.000266	CcSEcCtD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—AVP—lung cancer	0.000144	0.00171	CbGpPWpGaD
Sibutramine—Infection—Docetaxel—lung cancer	0.000144	0.000265	CcSEcCtD
Sibutramine—Feeling abnormal—Etoposide—lung cancer	0.000143	0.000265	CcSEcCtD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000143	0.00171	CbGpPWpGaD
Sibutramine—Hyperglycaemia—Doxorubicin—lung cancer	0.000143	0.000264	CcSEcCtD
Sibutramine—Diarrhoea—Irinotecan—lung cancer	0.000143	0.000264	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—GNG11—lung cancer	0.000142	0.0017	CbGpPWpGaD
Sibutramine—Pneumonia—Doxorubicin—lung cancer	0.000142	0.000263	CcSEcCtD
Sibutramine—Gastrointestinal pain—Etoposide—lung cancer	0.000142	0.000263	CcSEcCtD
Sibutramine—Shock—Docetaxel—lung cancer	0.000142	0.000263	CcSEcCtD
Sibutramine—Thrombocytopenia—Docetaxel—lung cancer	0.000141	0.000261	CcSEcCtD
Sibutramine—Visual impairment—Methotrexate—lung cancer	0.000141	0.000261	CcSEcCtD
Sibutramine—Tachycardia—Docetaxel—lung cancer	0.000141	0.000261	CcSEcCtD
Sibutramine—Feeling abnormal—Paclitaxel—lung cancer	0.00014	0.00026	CcSEcCtD
Sibutramine—Skin disorder—Docetaxel—lung cancer	0.00014	0.000259	CcSEcCtD
Sibutramine—Hypersensitivity—Cisplatin—lung cancer	0.00014	0.000258	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CASP3—lung cancer	0.00014	0.00167	CbGpPWpGaD
Sibutramine—Gastrointestinal pain—Paclitaxel—lung cancer	0.000139	0.000258	CcSEcCtD
Sibutramine—Diarrhoea—Gemcitabine—lung cancer	0.000139	0.000257	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000139	0.00166	CbGpPWpGaD
Sibutramine—Renal failure—Doxorubicin—lung cancer	0.000139	0.000257	CcSEcCtD
Sibutramine—Neuropathy peripheral—Doxorubicin—lung cancer	0.000139	0.000256	CcSEcCtD
Sibutramine—Dizziness—Irinotecan—lung cancer	0.000138	0.000255	CcSEcCtD
Sibutramine—Urticaria—Etoposide—lung cancer	0.000138	0.000255	CcSEcCtD
Sibutramine—Stomatitis—Doxorubicin—lung cancer	0.000138	0.000255	CcSEcCtD
Sibutramine—Anorexia—Docetaxel—lung cancer	0.000138	0.000254	CcSEcCtD
Sibutramine—Body temperature increased—Etoposide—lung cancer	0.000137	0.000254	CcSEcCtD
Sibutramine—Abdominal pain—Etoposide—lung cancer	0.000137	0.000254	CcSEcCtD
Sibutramine—Urinary tract infection—Doxorubicin—lung cancer	0.000137	0.000254	CcSEcCtD
Sibutramine—Conjunctivitis—Doxorubicin—lung cancer	0.000137	0.000254	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—GSTA3—lung cancer	0.000137	0.00164	CbGpPWpGaD
Sibutramine—Eye disorder—Methotrexate—lung cancer	0.000137	0.000253	CcSEcCtD
Sibutramine—Tinnitus—Methotrexate—lung cancer	0.000137	0.000253	CcSEcCtD
Sibutramine—Asthenia—Cisplatin—lung cancer	0.000136	0.000252	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—JUN—lung cancer	0.000136	0.00162	CbGpPWpGaD
Sibutramine—Sweating—Doxorubicin—lung cancer	0.000136	0.00025	CcSEcCtD
Sibutramine—Urticaria—Paclitaxel—lung cancer	0.000135	0.00025	CcSEcCtD
Sibutramine—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	0.000135	0.00161	CbGpPWpGaD
Sibutramine—Hypotension—Docetaxel—lung cancer	0.000135	0.000249	CcSEcCtD
Sibutramine—Haematuria—Doxorubicin—lung cancer	0.000135	0.000249	CcSEcCtD
Sibutramine—Body temperature increased—Paclitaxel—lung cancer	0.000135	0.000249	CcSEcCtD
Sibutramine—Abdominal pain—Paclitaxel—lung cancer	0.000135	0.000249	CcSEcCtD
Sibutramine—Epistaxis—Doxorubicin—lung cancer	0.000133	0.000246	CcSEcCtD
Sibutramine—Angiopathy—Methotrexate—lung cancer	0.000133	0.000246	CcSEcCtD
Sibutramine—Vomiting—Irinotecan—lung cancer	0.000133	0.000246	CcSEcCtD
Sibutramine—Sinusitis—Doxorubicin—lung cancer	0.000133	0.000245	CcSEcCtD
Sibutramine—Immune system disorder—Methotrexate—lung cancer	0.000132	0.000245	CcSEcCtD
Sibutramine—Rash—Irinotecan—lung cancer	0.000132	0.000244	CcSEcCtD
Sibutramine—Dermatitis—Irinotecan—lung cancer	0.000132	0.000243	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000132	0.000243	CcSEcCtD
Sibutramine—Chills—Methotrexate—lung cancer	0.000131	0.000243	CcSEcCtD
Sibutramine—Headache—Irinotecan—lung cancer	0.000131	0.000242	CcSEcCtD
Sibutramine—Insomnia—Docetaxel—lung cancer	0.000131	0.000241	CcSEcCtD
Sibutramine—Diarrhoea—Cisplatin—lung cancer	0.00013	0.00024	CcSEcCtD
Sibutramine—Paraesthesia—Docetaxel—lung cancer	0.00013	0.00024	CcSEcCtD
Sibutramine—Alopecia—Methotrexate—lung cancer	0.000129	0.000239	CcSEcCtD
Sibutramine—Vomiting—Gemcitabine—lung cancer	0.000129	0.000239	CcSEcCtD
Sibutramine—Bradycardia—Doxorubicin—lung cancer	0.000129	0.000239	CcSEcCtD
Sibutramine—Dyspnoea—Docetaxel—lung cancer	0.000129	0.000238	CcSEcCtD
Sibutramine—Somnolence—Docetaxel—lung cancer	0.000128	0.000237	CcSEcCtD
Sibutramine—Rash—Gemcitabine—lung cancer	0.000128	0.000237	CcSEcCtD
Sibutramine—Dermatitis—Gemcitabine—lung cancer	0.000128	0.000237	CcSEcCtD
Sibutramine—Hypersensitivity—Etoposide—lung cancer	0.000128	0.000237	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000128	0.00153	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000128	0.00153	CbGpPWpGaD
Sibutramine—Malnutrition—Methotrexate—lung cancer	0.000128	0.000236	CcSEcCtD
Sibutramine—Haemoglobin—Doxorubicin—lung cancer	0.000128	0.000236	CcSEcCtD
Sibutramine—Headache—Gemcitabine—lung cancer	0.000128	0.000236	CcSEcCtD
Sibutramine—Rhinitis—Doxorubicin—lung cancer	0.000127	0.000235	CcSEcCtD
Sibutramine—Dyspepsia—Docetaxel—lung cancer	0.000127	0.000235	CcSEcCtD
Sibutramine—Haemorrhage—Doxorubicin—lung cancer	0.000127	0.000235	CcSEcCtD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000127	0.00151	CbGpPWpGaD
Sibutramine—Hypoaesthesia—Doxorubicin—lung cancer	0.000126	0.000233	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—GNG11—lung cancer	0.000126	0.0015	CbGpPWpGaD
Sibutramine—Pharyngitis—Doxorubicin—lung cancer	0.000126	0.000233	CcSEcCtD
Sibutramine—Decreased appetite—Docetaxel—lung cancer	0.000126	0.000232	CcSEcCtD
Sibutramine—Hypersensitivity—Paclitaxel—lung cancer	0.000126	0.000232	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—GSTA4—lung cancer	0.000126	0.0015	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—EP300—lung cancer	0.000125	0.00149	CbGpPWpGaD
Sibutramine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000125	0.00149	CbGpPWpGaD
Sibutramine—Oedema peripheral—Doxorubicin—lung cancer	0.000125	0.000231	CcSEcCtD
Sibutramine—Dysgeusia—Methotrexate—lung cancer	0.000125	0.000231	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Docetaxel—lung cancer	0.000125	0.000231	CcSEcCtD
Sibutramine—Asthenia—Etoposide—lung cancer	0.000125	0.00023	CcSEcCtD
Sibutramine—Nausea—Irinotecan—lung cancer	0.000124	0.000229	CcSEcCtD
Sibutramine—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	0.000124	0.00148	CbGpPWpGaD
Sibutramine—Constipation—Docetaxel—lung cancer	0.000124	0.000228	CcSEcCtD
Sibutramine—Pain—Docetaxel—lung cancer	0.000124	0.000228	CcSEcCtD
Sibutramine—Back pain—Methotrexate—lung cancer	0.000123	0.000228	CcSEcCtD
Sibutramine—Pruritus—Etoposide—lung cancer	0.000123	0.000227	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—GSTA2—lung cancer	0.000122	0.00146	CbGpPWpGaD
Sibutramine—Visual impairment—Doxorubicin—lung cancer	0.000122	0.000226	CcSEcCtD
Sibutramine—Asthenia—Paclitaxel—lung cancer	0.000122	0.000226	CcSEcCtD
Sibutramine—Nausea—Gemcitabine—lung cancer	0.000121	0.000223	CcSEcCtD
Sibutramine—Vomiting—Cisplatin—lung cancer	0.000121	0.000223	CcSEcCtD
Sibutramine—Pruritus—Paclitaxel—lung cancer	0.000121	0.000223	CcSEcCtD
Sibutramine—Vision blurred—Methotrexate—lung cancer	0.00012	0.000222	CcSEcCtD
Sibutramine—Rash—Cisplatin—lung cancer	0.00012	0.000221	CcSEcCtD
Sibutramine—Dermatitis—Cisplatin—lung cancer	0.00012	0.000221	CcSEcCtD
Sibutramine—Feeling abnormal—Docetaxel—lung cancer	0.000119	0.00022	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—TF—lung cancer	0.000119	0.00142	CbGpPWpGaD
Sibutramine—Diarrhoea—Etoposide—lung cancer	0.000119	0.00022	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000119	0.00141	CbGpPWpGaD
Sibutramine—Eye disorder—Doxorubicin—lung cancer	0.000119	0.000219	CcSEcCtD
Sibutramine—Ill-defined disorder—Methotrexate—lung cancer	0.000118	0.000219	CcSEcCtD
Sibutramine—Tinnitus—Doxorubicin—lung cancer	0.000118	0.000219	CcSEcCtD
Sibutramine—Gastrointestinal pain—Docetaxel—lung cancer	0.000118	0.000218	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—GSTA1—lung cancer	0.000118	0.00141	CbGpPWpGaD
Sibutramine—Anaemia—Methotrexate—lung cancer	0.000118	0.000218	CcSEcCtD
Sibutramine—Diarrhoea—Paclitaxel—lung cancer	0.000117	0.000216	CcSEcCtD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—BRAF—lung cancer	0.000116	0.00139	CbGpPWpGaD
Sibutramine—Angiopathy—Doxorubicin—lung cancer	0.000115	0.000213	CcSEcCtD
Sibutramine—Malaise—Methotrexate—lung cancer	0.000115	0.000213	CcSEcCtD
Sibutramine—Dizziness—Etoposide—lung cancer	0.000115	0.000212	CcSEcCtD
Sibutramine—Immune system disorder—Doxorubicin—lung cancer	0.000115	0.000212	CcSEcCtD
Sibutramine—Vertigo—Methotrexate—lung cancer	0.000115	0.000212	CcSEcCtD
Sibutramine—Body temperature increased—Docetaxel—lung cancer	0.000114	0.000211	CcSEcCtD
Sibutramine—Abdominal pain—Docetaxel—lung cancer	0.000114	0.000211	CcSEcCtD
Sibutramine—Leukopenia—Methotrexate—lung cancer	0.000114	0.000211	CcSEcCtD
Sibutramine—Chills—Doxorubicin—lung cancer	0.000114	0.00021	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000113	0.00135	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000113	0.00135	CbGpPWpGaD
Sibutramine—Arrhythmia—Doxorubicin—lung cancer	0.000113	0.00021	CcSEcCtD
Sibutramine—Dizziness—Paclitaxel—lung cancer	0.000113	0.000208	CcSEcCtD
Sibutramine—Nausea—Cisplatin—lung cancer	0.000113	0.000208	CcSEcCtD
Sibutramine—Alopecia—Doxorubicin—lung cancer	0.000112	0.000207	CcSEcCtD
Sibutramine—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	0.000111	0.00133	CbGpPWpGaD
Sibutramine—Cough—Methotrexate—lung cancer	0.000111	0.000206	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—JUN—lung cancer	0.000111	0.00132	CbGpPWpGaD
Sibutramine—Convulsion—Methotrexate—lung cancer	0.000111	0.000204	CcSEcCtD
Sibutramine—Vomiting—Etoposide—lung cancer	0.000111	0.000204	CcSEcCtD
Sibutramine—Malnutrition—Doxorubicin—lung cancer	0.00011	0.000204	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—UGT1A1—lung cancer	0.00011	0.00131	CbGpPWpGaD
Sibutramine—Rash—Etoposide—lung cancer	0.00011	0.000203	CcSEcCtD
Sibutramine—Dermatitis—Etoposide—lung cancer	0.000109	0.000202	CcSEcCtD
Sibutramine—Headache—Etoposide—lung cancer	0.000109	0.000201	CcSEcCtD
Sibutramine—Flatulence—Doxorubicin—lung cancer	0.000109	0.000201	CcSEcCtD
Sibutramine—Arthralgia—Methotrexate—lung cancer	0.000109	0.000201	CcSEcCtD
Sibutramine—Chest pain—Methotrexate—lung cancer	0.000109	0.000201	CcSEcCtD
Sibutramine—Myalgia—Methotrexate—lung cancer	0.000109	0.000201	CcSEcCtD
Sibutramine—Tension—Doxorubicin—lung cancer	0.000108	0.0002	CcSEcCtD
Sibutramine—Vomiting—Paclitaxel—lung cancer	0.000108	0.0002	CcSEcCtD
Sibutramine—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	0.000108	0.00129	CbGpPWpGaD
Sibutramine—Dysgeusia—Doxorubicin—lung cancer	0.000108	0.0002	CcSEcCtD
Sibutramine—Rash—Paclitaxel—lung cancer	0.000107	0.000199	CcSEcCtD
Sibutramine—Dermatitis—Paclitaxel—lung cancer	0.000107	0.000198	CcSEcCtD
Sibutramine—Discomfort—Methotrexate—lung cancer	0.000107	0.000198	CcSEcCtD
Sibutramine—Nervousness—Doxorubicin—lung cancer	0.000107	0.000198	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—PTEN—lung cancer	0.000107	0.00128	CbGpPWpGaD
Sibutramine—Back pain—Doxorubicin—lung cancer	0.000107	0.000197	CcSEcCtD
Sibutramine—Headache—Paclitaxel—lung cancer	0.000107	0.000197	CcSEcCtD
Sibutramine—Hypersensitivity—Docetaxel—lung cancer	0.000106	0.000197	CcSEcCtD
Sibutramine—Muscle spasms—Doxorubicin—lung cancer	0.000106	0.000196	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—TF—lung cancer	0.000105	0.00126	CbGpPWpGaD
Sibutramine—Confusional state—Methotrexate—lung cancer	0.000105	0.000194	CcSEcCtD
Sibutramine—Anaphylactic shock—Methotrexate—lung cancer	0.000104	0.000192	CcSEcCtD
Sibutramine—Vision blurred—Doxorubicin—lung cancer	0.000104	0.000192	CcSEcCtD
Sibutramine—Asthenia—Docetaxel—lung cancer	0.000104	0.000192	CcSEcCtD
Sibutramine—Infection—Methotrexate—lung cancer	0.000103	0.000191	CcSEcCtD
Sibutramine—Nausea—Etoposide—lung cancer	0.000103	0.000191	CcSEcCtD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000103	0.00123	CbGpPWpGaD
Sibutramine—Ill-defined disorder—Doxorubicin—lung cancer	0.000102	0.000189	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—EP300—lung cancer	0.000102	0.00122	CbGpPWpGaD
Sibutramine—Pruritus—Docetaxel—lung cancer	0.000102	0.000189	CcSEcCtD
Sibutramine—Anaemia—Doxorubicin—lung cancer	0.000102	0.000189	CcSEcCtD
Sibutramine—Thrombocytopenia—Methotrexate—lung cancer	0.000102	0.000188	CcSEcCtD
Sibutramine—Agitation—Doxorubicin—lung cancer	0.000102	0.000188	CcSEcCtD
Sibutramine—Nausea—Paclitaxel—lung cancer	0.000101	0.000187	CcSEcCtD
Sibutramine—Skin disorder—Methotrexate—lung cancer	0.000101	0.000187	CcSEcCtD
Sibutramine—Hyperhidrosis—Methotrexate—lung cancer	0.000101	0.000186	CcSEcCtD
Sibutramine—Malaise—Doxorubicin—lung cancer	9.96e-05	0.000184	CcSEcCtD
Sibutramine—Vertigo—Doxorubicin—lung cancer	9.92e-05	0.000183	CcSEcCtD
Sibutramine—Anorexia—Methotrexate—lung cancer	9.92e-05	0.000183	CcSEcCtD
Sibutramine—Syncope—Doxorubicin—lung cancer	9.91e-05	0.000183	CcSEcCtD
Sibutramine—Leukopenia—Doxorubicin—lung cancer	9.89e-05	0.000183	CcSEcCtD
Sibutramine—Diarrhoea—Docetaxel—lung cancer	9.88e-05	0.000183	CcSEcCtD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—ALB—lung cancer	9.83e-05	0.00117	CbGpPWpGaD
Sibutramine—Palpitations—Doxorubicin—lung cancer	9.76e-05	0.00018	CcSEcCtD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—MDM2—lung cancer	9.75e-05	0.00116	CbGpPWpGaD
Sibutramine—Hypotension—Methotrexate—lung cancer	9.73e-05	0.00018	CcSEcCtD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—RAF1—lung cancer	9.72e-05	0.00116	CbGpPWpGaD
Sibutramine—Loss of consciousness—Doxorubicin—lung cancer	9.71e-05	0.000179	CcSEcCtD
Sibutramine—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	9.68e-05	0.00115	CbGpPWpGaD
Sibutramine—Cough—Doxorubicin—lung cancer	9.64e-05	0.000178	CcSEcCtD
Sibutramine—Convulsion—Doxorubicin—lung cancer	9.57e-05	0.000177	CcSEcCtD
Sibutramine—Dizziness—Docetaxel—lung cancer	9.55e-05	0.000177	CcSEcCtD
Sibutramine—Hypertension—Doxorubicin—lung cancer	9.54e-05	0.000176	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Methotrexate—lung cancer	9.49e-05	0.000175	CcSEcCtD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	9.46e-05	0.00113	CbGpPWpGaD
Sibutramine—Insomnia—Methotrexate—lung cancer	9.42e-05	0.000174	CcSEcCtD
Sibutramine—Arthralgia—Doxorubicin—lung cancer	9.4e-05	0.000174	CcSEcCtD
Sibutramine—Myalgia—Doxorubicin—lung cancer	9.4e-05	0.000174	CcSEcCtD
Sibutramine—Chest pain—Doxorubicin—lung cancer	9.4e-05	0.000174	CcSEcCtD
Sibutramine—Anxiety—Doxorubicin—lung cancer	9.37e-05	0.000173	CcSEcCtD
Sibutramine—Paraesthesia—Methotrexate—lung cancer	9.35e-05	0.000173	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—HPGDS—lung cancer	9.33e-05	0.00111	CbGpPWpGaD
Sibutramine—Discomfort—Doxorubicin—lung cancer	9.29e-05	0.000172	CcSEcCtD
Sibutramine—Dyspnoea—Methotrexate—lung cancer	9.28e-05	0.000172	CcSEcCtD
Sibutramine—Somnolence—Methotrexate—lung cancer	9.26e-05	0.000171	CcSEcCtD
Sibutramine—Dry mouth—Doxorubicin—lung cancer	9.2e-05	0.00017	CcSEcCtD
Sibutramine—Vomiting—Docetaxel—lung cancer	9.18e-05	0.00017	CcSEcCtD
Sibutramine—Dyspepsia—Methotrexate—lung cancer	9.16e-05	0.000169	CcSEcCtD
Sibutramine—Rash—Docetaxel—lung cancer	9.11e-05	0.000168	CcSEcCtD
Sibutramine—Dermatitis—Docetaxel—lung cancer	9.1e-05	0.000168	CcSEcCtD
Sibutramine—Confusional state—Doxorubicin—lung cancer	9.09e-05	0.000168	CcSEcCtD
Sibutramine—Decreased appetite—Methotrexate—lung cancer	9.05e-05	0.000167	CcSEcCtD
Sibutramine—Headache—Docetaxel—lung cancer	9.05e-05	0.000167	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—GSTT1—lung cancer	9.05e-05	0.00108	CbGpPWpGaD
Sibutramine—Oedema—Doxorubicin—lung cancer	9.01e-05	0.000167	CcSEcCtD
Sibutramine—Anaphylactic shock—Doxorubicin—lung cancer	9.01e-05	0.000167	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Methotrexate—lung cancer	8.99e-05	0.000166	CcSEcCtD
Sibutramine—Infection—Doxorubicin—lung cancer	8.96e-05	0.000166	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—GCLC—lung cancer	8.94e-05	0.00107	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—CYP2A6—lung cancer	8.94e-05	0.00107	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—BRAF—lung cancer	8.92e-05	0.00106	CbGpPWpGaD
Sibutramine—Pain—Methotrexate—lung cancer	8.9e-05	0.000165	CcSEcCtD
Sibutramine—Shock—Doxorubicin—lung cancer	8.87e-05	0.000164	CcSEcCtD
Sibutramine—Thrombocytopenia—Doxorubicin—lung cancer	8.83e-05	0.000163	CcSEcCtD
Sibutramine—Tachycardia—Doxorubicin—lung cancer	8.8e-05	0.000163	CcSEcCtD
Sibutramine—Skin disorder—Doxorubicin—lung cancer	8.76e-05	0.000162	CcSEcCtD
Sibutramine—Hyperhidrosis—Doxorubicin—lung cancer	8.71e-05	0.000161	CcSEcCtD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—ALB—lung cancer	8.71e-05	0.00104	CbGpPWpGaD
Sibutramine—Anorexia—Doxorubicin—lung cancer	8.59e-05	0.000159	CcSEcCtD
Sibutramine—Nausea—Docetaxel—lung cancer	8.58e-05	0.000159	CcSEcCtD
Sibutramine—Feeling abnormal—Methotrexate—lung cancer	8.58e-05	0.000159	CcSEcCtD
Sibutramine—Gastrointestinal pain—Methotrexate—lung cancer	8.51e-05	0.000157	CcSEcCtD
Sibutramine—Hypotension—Doxorubicin—lung cancer	8.42e-05	0.000156	CcSEcCtD
Sibutramine—Urticaria—Methotrexate—lung cancer	8.27e-05	0.000153	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—AVP—lung cancer	8.25e-05	0.000983	CbGpPWpGaD
Sibutramine—Body temperature increased—Methotrexate—lung cancer	8.23e-05	0.000152	CcSEcCtD
Sibutramine—Abdominal pain—Methotrexate—lung cancer	8.23e-05	0.000152	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Doxorubicin—lung cancer	8.21e-05	0.000152	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL6—lung cancer	8.2e-05	0.000978	CbGpPWpGaD
Sibutramine—Insomnia—Doxorubicin—lung cancer	8.15e-05	0.000151	CcSEcCtD
Sibutramine—Paraesthesia—Doxorubicin—lung cancer	8.09e-05	0.00015	CcSEcCtD
Sibutramine—Dyspnoea—Doxorubicin—lung cancer	8.04e-05	0.000149	CcSEcCtD
Sibutramine—Somnolence—Doxorubicin—lung cancer	8.01e-05	0.000148	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ABCB1—lung cancer	7.99e-05	0.000952	CbGpPWpGaD
Sibutramine—Dyspepsia—Doxorubicin—lung cancer	7.94e-05	0.000147	CcSEcCtD
Sibutramine—Decreased appetite—Doxorubicin—lung cancer	7.84e-05	0.000145	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Doxorubicin—lung cancer	7.78e-05	0.000144	CcSEcCtD
Sibutramine—Constipation—Doxorubicin—lung cancer	7.71e-05	0.000142	CcSEcCtD
Sibutramine—Pain—Doxorubicin—lung cancer	7.71e-05	0.000142	CcSEcCtD
Sibutramine—Hypersensitivity—Methotrexate—lung cancer	7.67e-05	0.000142	CcSEcCtD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	7.67e-05	0.000914	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—CYP2E1—lung cancer	7.6e-05	0.000907	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	7.5e-05	0.000894	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—MDM2—lung cancer	7.47e-05	0.000891	CbGpPWpGaD
Sibutramine—Asthenia—Methotrexate—lung cancer	7.47e-05	0.000138	CcSEcCtD
Sibutramine—SLC6A3—Neuronal System—RAF1—lung cancer	7.45e-05	0.000888	CbGpPWpGaD
Sibutramine—Feeling abnormal—Doxorubicin—lung cancer	7.43e-05	0.000137	CcSEcCtD
Sibutramine—Gastrointestinal pain—Doxorubicin—lung cancer	7.37e-05	0.000136	CcSEcCtD
Sibutramine—Pruritus—Methotrexate—lung cancer	7.37e-05	0.000136	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—TP53—lung cancer	7.32e-05	0.000872	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—AVP—lung cancer	7.31e-05	0.000871	CbGpPWpGaD
Sibutramine—Urticaria—Doxorubicin—lung cancer	7.16e-05	0.000132	CcSEcCtD
Sibutramine—Body temperature increased—Doxorubicin—lung cancer	7.13e-05	0.000132	CcSEcCtD
Sibutramine—Abdominal pain—Doxorubicin—lung cancer	7.13e-05	0.000132	CcSEcCtD
Sibutramine—Diarrhoea—Methotrexate—lung cancer	7.12e-05	0.000132	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ABCB1—lung cancer	7.08e-05	0.000844	CbGpPWpGaD
Sibutramine—Dizziness—Methotrexate—lung cancer	6.88e-05	0.000127	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—IL6—lung cancer	6.7e-05	0.000798	CbGpPWpGaD
Sibutramine—Hypersensitivity—Doxorubicin—lung cancer	6.64e-05	0.000123	CcSEcCtD
Sibutramine—Vomiting—Methotrexate—lung cancer	6.62e-05	0.000122	CcSEcCtD
Sibutramine—Rash—Methotrexate—lung cancer	6.56e-05	0.000121	CcSEcCtD
Sibutramine—Dermatitis—Methotrexate—lung cancer	6.56e-05	0.000121	CcSEcCtD
Sibutramine—Headache—Methotrexate—lung cancer	6.52e-05	0.000121	CcSEcCtD
Sibutramine—Asthenia—Doxorubicin—lung cancer	6.47e-05	0.00012	CcSEcCtD
Sibutramine—Pruritus—Doxorubicin—lung cancer	6.38e-05	0.000118	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—APOA1—lung cancer	6.31e-05	0.000752	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTP1—lung cancer	6.27e-05	0.000748	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	6.18e-05	0.000737	CbGpPWpGaD
Sibutramine—Nausea—Methotrexate—lung cancer	6.18e-05	0.000114	CcSEcCtD
Sibutramine—Diarrhoea—Doxorubicin—lung cancer	6.17e-05	0.000114	CcSEcCtD
Sibutramine—Dizziness—Doxorubicin—lung cancer	5.96e-05	0.00011	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—GSTM1—lung cancer	5.76e-05	0.000687	CbGpPWpGaD
Sibutramine—Vomiting—Doxorubicin—lung cancer	5.73e-05	0.000106	CcSEcCtD
Sibutramine—Rash—Doxorubicin—lung cancer	5.68e-05	0.000105	CcSEcCtD
Sibutramine—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	5.68e-05	0.000678	CbGpPWpGaD
Sibutramine—Dermatitis—Doxorubicin—lung cancer	5.68e-05	0.000105	CcSEcCtD
Sibutramine—Headache—Doxorubicin—lung cancer	5.65e-05	0.000104	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—APOA1—lung cancer	5.59e-05	0.000666	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—CYP1A1—lung cancer	5.46e-05	0.000651	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	5.39e-05	0.000642	CbGpPWpGaD
Sibutramine—Nausea—Doxorubicin—lung cancer	5.35e-05	9.9e-05	CcSEcCtD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—HRAS—lung cancer	5.35e-05	0.000638	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—CREBBP—lung cancer	5.34e-05	0.000637	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ALB—lung cancer	5e-05	0.000596	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—COL4A3BP—lung cancer	4.81e-05	0.000573	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—AZIN2—lung cancer	4.81e-05	0.000573	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—CREBBP—lung cancer	4.73e-05	0.000564	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—RAF1—lung cancer	4.52e-05	0.000539	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ALB—lung cancer	4.43e-05	0.000528	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—HRAS—lung cancer	4.1e-05	0.000489	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ATP5H—lung cancer	4.09e-05	0.000487	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—POMC—lung cancer	4.07e-05	0.000486	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—RAF1—lung cancer	4e-05	0.000477	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PLBD1—lung cancer	3.64e-05	0.000434	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HSD17B10—lung cancer	3.33e-05	0.000397	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CKB—lung cancer	3.1e-05	0.000369	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTM2—lung cancer	2.91e-05	0.000347	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CNDP2—lung cancer	2.91e-05	0.000347	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—MTMR3—lung cancer	2.83e-05	0.000338	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PGAM1—lung cancer	2.76e-05	0.000329	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP2A7—lung cancer	2.63e-05	0.000314	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SDC4—lung cancer	2.58e-05	0.000307	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—RRM1—lung cancer	2.35e-05	0.00028	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTA3—lung cancer	2.35e-05	0.00028	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—B4GALT5—lung cancer	2.21e-05	0.000263	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTA4—lung cancer	2.15e-05	0.000256	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTA2—lung cancer	2.09e-05	0.000249	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTA1—lung cancer	2.02e-05	0.000241	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ABCC3—lung cancer	2e-05	0.000238	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—AKR1C1—lung cancer	1.93e-05	0.00023	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—UGT1A1—lung cancer	1.88e-05	0.000224	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GNG11—lung cancer	1.81e-05	0.000216	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALDOA—lung cancer	1.72e-05	0.000205	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NCOA3—lung cancer	1.67e-05	0.000199	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ADCY1—lung cancer	1.63e-05	0.000194	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ABCG2—lung cancer	1.63e-05	0.000194	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HPGDS—lung cancer	1.6e-05	0.00019	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ENO2—lung cancer	1.6e-05	0.00019	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.59e-05	0.000189	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTT1—lung cancer	1.55e-05	0.000184	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP2A6—lung cancer	1.53e-05	0.000182	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GCLC—lung cancer	1.53e-05	0.000182	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ENO1—lung cancer	1.45e-05	0.000173	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP2E1—lung cancer	1.3e-05	0.000155	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NQO1—lung cancer	1.29e-05	0.000153	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—STK11—lung cancer	1.16e-05	0.000138	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTP1—lung cancer	1.07e-05	0.000128	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CAT—lung cancer	1.04e-05	0.000124	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ABCB1—lung cancer	1.02e-05	0.000121	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—TYMS—lung cancer	9.97e-06	0.000119	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTM1—lung cancer	9.86e-06	0.000117	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP1A1—lung cancer	9.34e-06	0.000111	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ERCC2—lung cancer	9.27e-06	0.00011	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—APOA1—lung cancer	8.02e-06	9.56e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3CG—lung cancer	7.32e-06	8.72e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—POMC—lung cancer	6.97e-06	8.3e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CREBBP—lung cancer	6.78e-06	8.09e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3CD—lung cancer	6.43e-06	7.67e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALB—lung cancer	6.35e-06	7.57e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3CB—lung cancer	5.61e-06	6.68e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PTGS2—lung cancer	5.56e-06	6.62e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PTEN—lung cancer	4.85e-06	5.78e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—EP300—lung cancer	4.62e-06	5.51e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3CA—lung cancer	3.42e-06	4.08e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—AKT1—lung cancer	2.79e-06	3.33e-05	CbGpPWpGaD
